These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 11430918)
21. Dextromethorphan interactions with histaminergic and serotonergic treatments to reduce nicotine self-administration in rats. Briggs SA; Hall BJ; Wells C; Slade S; Jaskowski P; Morrison M; Rezvani AH; Rose JE; Levin ED Pharmacol Biochem Behav; 2016 Mar; 142():1-7. PubMed ID: 26704812 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. Chaplan SR; Malmberg AB; Yaksh TL J Pharmacol Exp Ther; 1997 Feb; 280(2):829-38. PubMed ID: 9023297 [TBL] [Abstract][Full Text] [Related]
23. Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment. Maisonneuve IM; Glick SD Pharmacol Biochem Behav; 2003 Jun; 75(3):607-18. PubMed ID: 12895678 [TBL] [Abstract][Full Text] [Related]
24. N-methyl-D-aspartate (NMDA) antagonists--S(+)-ketamine, dextrorphan, and dextromethorphan--act as calcium antagonists on bovine cerebral arteries. Kamel IR; Wendling WW; Chen D; Wendling KS; Harakal C; Carlsson C J Neurosurg Anesthesiol; 2008 Oct; 20(4):241-8. PubMed ID: 18812887 [TBL] [Abstract][Full Text] [Related]
25. L-methamphetamine and selective MAO inhibitors decrease morphine-reinforced and non-reinforced behavior in rats; Insights towards selegiline's mechanism of action. He S; Grasing K Pharmacol Biochem Behav; 2006 Dec; 85(4):675-88. PubMed ID: 17157368 [TBL] [Abstract][Full Text] [Related]
26. Modulation of nicotine self-administration in rats by combination therapy with agents blocking alpha 3 beta 4 nicotinic receptors. Glick SD; Maisonneuve IM; Kitchen BA Eur J Pharmacol; 2002 Jul; 448(2-3):185-91. PubMed ID: 12144940 [TBL] [Abstract][Full Text] [Related]
27. An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan. Lauterbach EC Med Hypotheses; 2012 Jun; 78(6):693-702. PubMed ID: 22401777 [TBL] [Abstract][Full Text] [Related]
28. Co-administration of dextromethorphan with methamphetamine attenuates methamphetamine-induced rewarding and behavioral sensitization. Yang PP; Huang EY; Yeh GC; Tao PL J Biomed Sci; 2006 Sep; 13(5):695-702. PubMed ID: 16865411 [TBL] [Abstract][Full Text] [Related]
29. Dextromethorphan inhibits but dextrorphan potentiates behavior induced by PCP and ketamine in rats. Székely JI; Sharpe LG; Jaffe JH NIDA Res Monogr; 1990; 105():341-4. PubMed ID: 1876034 [No Abstract] [Full Text] [Related]
30. Post-treatment of dextromethorphan on methamphetamine-induced drug-seeking and behavioral sensitization in rats. Yang PP; Huang EY; Fu YY; Ho TS; Tao PL Synapse; 2012 Oct; 66(10):858-69. PubMed ID: 22674496 [TBL] [Abstract][Full Text] [Related]
31. Differential antinociception by morphine and methadone in two sub-strains of Sprague-Dawley rats and its potentiation by dextromethorphan. Bulka A; Wiesenfeld-Hallin Z; Xu XJ Brain Res; 2002 Jun; 942(1-2):95-100. PubMed ID: 12031857 [TBL] [Abstract][Full Text] [Related]
32. Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan. Chou YC; Liao JF; Chang WY; Lin MF; Chen CF Brain Res; 1999 Mar; 821(2):516-9. PubMed ID: 10064839 [TBL] [Abstract][Full Text] [Related]
33. Discriminative stimulus properties of dextromethorphan in rats. Gavend M; Mallaret M; Dematteis M; Baragatti G Biomed Pharmacother; 1995; 49(10):456-64. PubMed ID: 8746072 [TBL] [Abstract][Full Text] [Related]
34. Comparative antitussive effects of dextrorphan, dextromethorphan and phencyclidine. Lal J; Krutak-Krol H; Domino EF Arzneimittelforschung; 1986 Jul; 36(7):1075-8. PubMed ID: 3768075 [TBL] [Abstract][Full Text] [Related]
35. Systemic dextromethorphan and dextrorphan are less toxic in rats than bupivacaine at equianesthetic doses. Chen YW; Wang JJ; Liu TY; Chen YC; Hung CH Can J Anaesth; 2011 Jan; 58(1):55-61. PubMed ID: 21042903 [TBL] [Abstract][Full Text] [Related]
36. Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration. Glick SD; Maisonneuve IM; Kitchen BA; Fleck MW Eur J Pharmacol; 2002 Mar; 438(1-2):99-105. PubMed ID: 11906717 [TBL] [Abstract][Full Text] [Related]
37. Dextromethorphan for the reduction of immediate and late postoperative pain and morphine consumption in orthopedic oncology patients: a randomized, placebo-controlled, double-blind study. Weinbroum AA; Gorodetzky A; Nirkin A; Kollender Y; Bickels J; Marouani N; Rudick V; Meller I Cancer; 2002 Sep; 95(5):1164-70. PubMed ID: 12209704 [TBL] [Abstract][Full Text] [Related]
38. Brain levels of dextromethorphan and the intensity of opioid withdrawal in mice. Bisaga A; Kos T; Wójcikowski J; Daniel WA; Popik P Drug Alcohol Depend; 2008 May; 95(1-2):147-51. PubMed ID: 18328640 [TBL] [Abstract][Full Text] [Related]
39. Dextromethorphan and dextrorphan as calcium channel antagonists. Carpenter CL; Marks SS; Watson DL; Greenberg DA Brain Res; 1988 Jan; 439(1-2):372-5. PubMed ID: 2451974 [TBL] [Abstract][Full Text] [Related]
40. Attenuation of the stimulant and convulsant effects of cocaine by 17-substituted-3-hydroxy and 3-alkoxy derivatives of dextromethorphan. Zapata A; Gasior M; Geter-Douglass B; Tortella FC; Newman AH; Witkin JM Pharmacol Biochem Behav; 2003 Jan; 74(2):313-23. PubMed ID: 12479950 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]